New and emerging therapies for collagen-vascular diseases.
Cutaneous disease is frequent in many of the rheumatic disorders. Some of these disorders such as lupus erythematosus, dermatomyositic, scleroderma, and vasculitis are defined by their cutaneous manifestations. As investigation increases our understanding of these disorders, available therapy becomes more logical and less empiric. This article deals with some of the newer therapies for these disorders.
Callen
J P
JP
Division of Dermatology, University of Louisville School of Medicine, Kentucky, USA. jefca@aol.com
D003882:Dermatomyositis / Q000628:therapy*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D012594:Scleroderma, Localized / Q000628:therapy*; D012867:Skin / Q000098:blood supply*; D014657:Vasculitis / Q000628:therapy*